Drug intelligence / Profile preview

Qingfei Runzao granules

Development stage
Preclinical
Lead developer
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Qingfei Runzao granules is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. It is specifically designed for the treatment of post-infectious cough (PIC) in children, particularly those presenting with the 'dryness' syndrome pattern according to TCM theory. As a granule preparation, it consists of a multi-herb botanical formulation intended to clear the lungs and moisten dryness to relieve persistent coughing following respiratory infections. The drug is currently being evaluated in clinical studies to determine its clinical efficacy and identify dominant biological targets in comparison to other pediatric cough treatments like Xiaoer cough syrup.

Brand names
Beijing Tongrentang Qingfei Runzao Granules
Other names
Qingfei-runzao granules
02

Targets

HSD11B2 (11β-HSD2)COX7C (Cytochrome c oxidase subunit 7C, mitochondrial)

Beyond the preview

Go deeper on Qingfei Runzao granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingfei Runzao granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call